News | Page 60 | Englander Institute for Precision Medicine

USF Health, Weill Cornell Medicine Earn Inaugural Funding in NIH’s Newly Launched Bridge2AI Initiative, will Create Artificial Intelligence Platform for Using Voice to Diagnose Disease

September 13, 2022

Tampa FL (Sept. 13, 2022) – Artificial intelligence may soon help doctors diagnose and treat diseases, including cancer and depression, based on the sound of a patient’s voice, as 12 leading research institutions launch a landmark National Institutes of Health-funded academic project that may establish voice as a biomarker used in clinical care.

The University of South Florida in Tampa, FL, is the lead institution on the project in collaboration with...

Biological Links Identified Between an Aggressive Breast Cancer Type and African Ancestry

September 5, 2022

Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer (TNBC). Their analysis of TNBC tumors from a diverse patient population yielded a large set of genes whose expression differed in patients with African ancestry compared with patients with European ancestry.

In the study, published Sept. 19 in ...

EIPM Clinical Director Dr. Cora N. Sternberg

September 2022 EIPM Director's Memo

September 1, 2022

Dear Members of the Englander Institute,

I hope you were able to take some time off this summer and relax with friends and family members, and hopefully recharge for a productive autumn.

As you’ll see below, members of the EIPM had a very productive August, with significant news media coverage of our work, presentations at major international conferences, and impactful publications in high-profile journals. Thank you all for the great work during the heat of the summer!

We...